Need some help?
If you have a general query or you wish to place a telephone order we are always happy to help.
Mon to Fri: 9am to 5pm
Mycology Research Reishi MRL 500mg 90 tablets
- Buy 4 for £23.81 each and save 10%
- Buy 12 for £22.48 each and save 15%
Mycology Research Reishi MRL 500mg 90 tablets
Reishi-MRL (Ganoderma lucidium) may supports the body´s normal cellular immune system. Ganoderma lucidium powder is not an extract of Ganoderma lucidium, the powder does contains both mycelium and primordia (young fruit body) cultivated into a biomass that is grown on a sterilised (autoclaved) substrate.Ganoderma lucidium is processed under the same rigorously controlled conditions that are applied to the manufacture of a conventional pharmaceutical. This ensures that each tablet contains 500 mg of standardised Ganoderma lucidium product. The tablets are film coated to protect them from moisture, thus preserving the quality of the product and ensuring a long shelf life.
After passing quality control testing the tablets are released for use. The choice of additives used in manufacture renders these tablets suitable for Kosher or vegetarian use.
Certified Organic: USA/EU The fungal biomass Coriolus versicolor that comprises Coriolus-MRL is certified 100% Organic in the United States by Quality Assurance International (Certificate No. 103491-A). In December of 2005, MRL powder gained EU organic certification in accordance with EU Council Regulation (EEC) No. 2092/91 by Quality Assurance International (Certificate No. 105493-A).
| Further Information | Ingredients for Reishi MRLChemical and Biological Properties Each Tablet of Reishi-MRL contains Ganoderma lucidium - biomass powder 500mg Other ingredients Microcrystalline Cellulose Silica Vegetable Magnesium Sterate Protein content 22.2 mg Reducing sugars 24.0 mg Protein-bound polysaccharide 69.5 mg Glucose 2-oxidase activity 8.2 mU Peroxidase activity 11.2 mU Laccase activity 451.5 mU Glucoamylase / beta-glucansase activity 2.7 U Protease activity 4.4 mU Superoxide dismutase (SOD) activity 50.4 mU Cytochrome P-450 0.66 nmoles Cytochrome P-450 reductase 7.05 mU Secondary metabolites (Thrombin inhibitors) 4.4% Directions for use: |
|---|
